Ryota Tanaka

31PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthPredictive and prognostic markersNeonatologySystems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 27, 2026
Risk Assessment of Neutropenia Based on Exposure Information Without Plasma Concentration Measurement in Pemetrexed-Platinum-Based Chemotherapy: A Modeling Approach Using Real-World Clinical Data.

|Jul 01, 2026
Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

|Jun 15, 2026
Association between anamorelin therapy and renal function in patients with cancer cachexia: a propensity score-matched retrospective study.

|Mar 17, 2026
Impact of Postnatal Changes in Creatinine Levels on Plasma Gentamicin Concentrations in Neonates.

Haruka Tsushita, Ryota Tanaka, Masanori Inoue

|Jan 28, 2026
Creatinine/cystatin C ratio-guided selection of renal function marker in sarcopenia.

Rina Kamiya, Ryota Tanaka, Haruka Tsushita

|Jul 24, 2025
Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic Analysis.

Alexandra Pyatt, Melissa McGowan, Ryota Tanaka

Pageof 6

Frequent Collaborators

8 joint publications

Ryosuke Tatsuta

8 joint publications

Yosuke Suzuki

4 joint publications

Takahiro Sumimoto

4 joint publications

Hiroki Itoh